Triple-Negative Breast Cancer (TNBC) Recruiting Phase 3 Trials for Filgrastim (DB00099)

Also known as: Triple-negative Breast Cancer

IndicationStatusPhase
DBCOND0067309 (Triple-Negative Breast Cancer (TNBC))Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs